Companies Mosaic Therapeutics

Targeted molecular cancer therapies created by breaking down cancer’s complexity


Mosaic Therapeutics is an oncology therapeutics company dedicated to resolving cancer’s complexity to power new treatments for patients, alone and in combination.

Built on over a decade of research from the Wellcome Sanger Institute, in collaboration with the Netherland’s Cancer Institute, Mosaic’s proprietary platform sits at the interface of computational and experimental medicine, driving the accelerated discovery of novel drugs and the precise identification of biomarkers to create the right drug, for the right patient.

Cambridge Innovation Capital is a leading Series A investor in the Cambridge ecosystem.

We were born out of a unique relationship with the University of Cambridge and we maintain privileged access to its most inspiring ideas and people in life sciences and deep tech.

Discover more


Read More